Discovery of 7-Tetrahydropyran-2-yl Chromans: β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors That Reduce Amyloid β-Protein (Aβ) in the Central Nervous System

详细信息    查看全文

• 作者：Allen A. Thomas ; Kevin W. Hunt ; Matthew Volgraf ; Ryan J. Watts ; Xingrong Liu ; Guy Vigers ; Darin Smith ; Douglas Sammond ; Tony P. Tang ; Susan P. Rhodes ; Andrew T. Metcalf ; Karin D. Brown ; Jennifer N. Otten ; Michael Burkard ; April A. Cox ; Mary K. Geck Do ; Darrin Dutcher ; Sumeet Rana ; Robert K. DeLisle ; Kelly Regal ; Albion D. Wright ; Robert Groneberg ; Kimberly Scearce-Levie ; Michael Siu ; Hans E. Purkey ; Joseph P. Lyssikatos ; Indrani W. Gunawardana
• 刊名：Journal of Medicinal Chemistry
• 出版年：2014
• 出版时间：February 13, 2014
• 年：2014
• 卷：57
• 期：3
• 页码：878-902
• 全文大小：888K
• ISSN：1520-4804

文摘

In an attempt to increase selectivity vs Cathepsin D (CatD) in our BACE1 program, a series of 1,3,4,4a,10,10a-hexahydropyrano[4,3-b]chromene analogues was developed. Three different Asp-binding moieties were examined: spirocyclic acyl guanidines, aminooxazolines, and aminothiazolines in order to modulate potency, selectivity, efflux, and permeability. Using structure-based design, substitutions to improve binding to both the S3 and S2鈥?sites of BACE1 were explored. An acyl guanidine moiety provided the most potent analogues. These compounds demonstrated 10鈥?20 fold selectivity for BACE1 vs CatD, and were highly potent in a cell assay measuring A尾_1鈥?0 production (5鈥?9 nM). They also suffered from high efflux. Despite this undesirable property, two of the acyl guanidines achieved free brain concentrations (C_free,brain) in a guinea pig PD model sufficient to cover their cell IC₅₀s. Moreover, a significant reduction of A尾_1鈥?0 in guinea pig, rat, and cyno CSF (58%, 53%, and 63%, respectively) was observed for compound 62.